$90Y-edotreotide for metastatic carcinoid refractory to octreotide.$

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

PURPOSE: Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushing, can be debilitating and occasionally life-threatening. Although symptom relief is available with octreotide, the disease eventually becomes refractory to octreotide, leaving no proven treatment o...

Full description

Bibliographic Details
Main Authors:	Bushnell, D, O'Dorisio, T, O'Dorisio, MS, Menda, Y, Hicks, R, Van Cutsem, E, Baulieu, J, Borson-Chazot, F, Anthony, L, Benson, AB, Oberg, K, Grossman, AB, Connolly, M, Bouterfa, H, Li, Y, Kacena, K, LaFrance, N, Pauwels, SA
Format:	Journal article
Language:	English
Published:	2010

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

Similar Items